Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0341-2023Class II

CytoCell BCL11B Distal in Texas Red Spectrum- Analyte Specific Reagent Ref: MPD39782

Cytocell Limited / initiated 2022-10-27 / Terminated / root cause: labeling and UDI

Cytocell Ltd. began a recall of CytoCell BCL11B Distal in Texas Red Spectrum- Analyte Specific Reagent Ref: MPD39782 on . FDA classified it as Class II and gives the reason as "An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0341-2023
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Cytocell Limited
Product
CytoCell BCL11B Distal in Texas Red Spectrum- Analyte Specific Reagent Ref: MPD39782
Product code
MVU Reagents, Specific, Analyte
Reason for recall
An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
CytoCell issued Urgent Medical Device Recall letter on 10/27/22 to end user via email. The letter states reason for recall, health risk and action to take: Immediately examine your inventory and quarantine all product subject to recall. Cytocell requests that all users review and implement the enclosed new package insert (v2) for this device. Please dispose of any copies of v1 of the package insert. Please complete and return the enclosed response form as soon as possible. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or [email protected].
Quantity in commerce
3 units
Distribution
TX
Product codes and lots
Lot Number: RD22/230/11

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0341-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0341-2023Class IITerminatedVoluntary: Firm initiated